Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- 1 February 2004
- journal article
- review article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 112 (2) , 136-141
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Contraceptive Efficacy and Tolerability of Chlormadinone Acetate 2mg/ Ethinylestradiol 0.03mg (Belara??)*Clinical Drug Investigation, 2002
- Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndromeHuman Reproduction, 2001
- THE EFFECTS OF VALETTE® ON SKIN AND HAIR: A POST‐MARKETING SURVEILLANCE STUDYInternational Journal Of Clinical Practice, 2000
- Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenoneThe European Journal of Contraception & Reproductive Health Care, 2000
- The efficacy of oral cyproterone acetate in combination with ethinyloestradiol in acne tarda of the facial typeJournal of Dermatological Treatment, 1998
- Clinical, Endocrinologic, and Ultrasonographic Features of Polycystic Ovary Syndrome in Singaporean AdolescentsJournal of Pediatric and Adolescent Gynecology, 1997
- Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activityContraception, 1995
- Antiandrogen therapy for signs of androgenization: an overview1987
- Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiolArchives of Gynecology and Obstetrics, 1985
- Therapy of androgenetic symptomatology with cyproterone acetate and ethinyl estradiolArchives of Gynecology and Obstetrics, 1978